The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab

por Pascal Gasser, Svetlana S. Tarchevskaya, Pascal Guntern, Daniel Brigger, Rahel Ruppli, Noemi Zbären, Silke Kleinboelting, Christoph Heusser, Theodore S. Jardetzky, Alexander Eggel
Publicado 2020